Axiom Medisurg Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 27-06-2024
- Paid Up Capital ₹ 2.11 Cr
as on 27-06-2024
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue -87.01%
(FY 2016)
- Profit -87.95%
(FY 2016)
- Ebitda -195.84%
(FY 2016)
- Net Worth 0.49%
(FY 2016)
- Total Assets -0.63%
(FY 2016)
About Axiom Medisurg
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jayprakash Mangtani, Girija Mangtani, Dipak Parmar, and One other member serve as directors at the Company.
- CIN/LLPIN
U33112GJ1989PLC012947
- Company No.
012947
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Oct 1989
- Date of AGM
30 Sep 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Axiom Medisurg?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayprakash Mangtani  | Director | 19-Feb-1996 | Current |
| Girija Mangtani | Director | 13-Nov-2010 | Current |
| Dipak Parmar | Director | Current | |
| Harshad Vaghela | Director | Current |
Financial Performance and Corporate Structure Insights of Axiom Medisurg.
Axiom Medisurg Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 87.01% decrease. The company also saw a substantial fall in profitability, with a 87.95% decrease in profit. The company's net worth moved up by a moderate rise of 0.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axiom Medisurg?
In 2017, Axiom Medisurg had a promoter holding of 46.49% and a public holding of 53.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Niho Construction LimitedActive 23 years 10 monthsJayprakash Mangtani and Girija Mangtani are mutual person
- Labh Construction And Industries LimitedActive 35 years 11 months
Jayprakash Mangtani, Girija Mangtani and 1 more are mutual person
- Lamaya Reality Private LimitedActive 5 years 3 months
Jayprakash Mangtani and Girija Mangtani are mutual person
- Niho Buildwell LimitedActive 19 years 2 months
Jayprakash Mangtani and Girija Mangtani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Axiom Medisurg?
Unlock and access historical data on people associated with Axiom Medisurg, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axiom Medisurg, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axiom Medisurg's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
